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Reactive oxygen species (ROS) have long been considered as pathological agents inducing apoptosis under adverse culture
conditions. However, recent findings have challenged this dogma and physiological levels of ROS are now considered as secondary
messengers, mediating numerous cellular functions in stem cells. Stem cells represent important tools for tissue engineering, drug
screening, and disease modeling. However, the safe use of stem cells for clinical applications still requires culture improvements
to obtain functional cells. With the examples of mesenchymal stem cells (MSCs) and pluripotent stem cells (PSCs), this review
investigates the roles of ROS in the maintenance of self-renewal, proliferation, and differentiation of stem cells. In addition, this
work highlights that the tight control of stem cell microenvironment, including cell organization, and metabolic and mechanical
environments, may be an effective approach to regulate endogenous ROS generation. Taken together, this paper indicates the need
for better quantification of ROS towards the accurate control of stem cell fate.
1. Introduction
Mesenchymal stem cells (MSCs) and pluripotent stem cells
(PSCs), including embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs), have emerged as important
tools for drug screening, disease modeling, and tissue engi-
neering [1, 2]. MSCs are progenitors of connective tissues,
bearing differentiation potential along osteoblasts, chondro-
cytes, and adipocytes [3]. MSCs are now evaluated in more
than 400 clinical trials due to their differentiation potential
and especially their trophic activities (i.e., the secretion of
antiapoptotic, anti-inflammatory, and antiscarring factors),
which constitute their major therapeutic effects in vivo [1].
Different from MSCs, ESCs are derived from inner mass of
the blastocyst and iPSCs are obtained by reprogramming
somatic cells to ESC-like pluripotent state by overexpression
of the pluripotent genes [4]. Both cell populations have differ-
entiation potential for a large spectrum of somatic cell types,
mimicking the embryonic development. However, there is
still a limited control of lineage-specific differentiation, which
impedes the high promise of PSCs for the treatment of
incurable diseases [5]. ForMSCs, the limited efficacy ofMSCs
in vivo also indicates the need to improve their therapeutic
functions in vitro prior to transplantation [6].
Once injected into damaged tissues, stem cells are
exposed to acute ischemia and oxygen deprivation, which
lead to the production of highly oxidizing compounds,
known as reactive oxygen species (ROS). Excessive ROS
would result in the apoptosis of the transplanted cells [7].
Similarly, exposure of stem cells to extreme culture con-
ditions in vitro (such as starvation, metabolic alterations,
and exposure to toxic molecules) also leads to the apoptosis
mediated by ROS [8, 9]. Thus, ROS has been recognized as
pathologicalmetabolic agents that reduce stem cell functions.
However, recent studies have challenged this dogma by
demonstrating the positive effects of physiological ROS for
the regulation of stem cell fate decision. For instance, hypoxia
results in mild levels of ROS (e.g., 1.8-fold of normal level),
which are actively involved in the regulation of proliferation
and differentiation of MSCs and PSCs [10, 11]. Moreover,
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the metabolic shift observed during stem cell commitment
leads to the increased levels of ROS which are intrinsically
linked with the differentiation stage of stem cells [12]. Hence,
it is becoming clear that physiological levels of ROS play a
role of secondary messengers in the regulation of stem cell
fate. As a consequence, the control of ROS generation could
lead to efficient stem cell expansion and differentiation.
This review investigates recent advances in the under-
standing of ROS generation and the mechanisms to sustain
the redox equilibrium in MSCs and PSCs. In addition, this
paper underlines how ROS positively or negatively interferes
with the signaling pathways that regulate stem cell survival,
proliferation and differentiation. Novel strategies for the tight
regulation of stem cell microenvironment which enables the
modulation of cellular redox status to control stem cell fate
are also discussed.
2. ROS Generation and Scavenging
in Stem Cells
Stem cell physiology and metabolism are tightly regulated
by oxidation-reduction events that mainly occur during
respiratory chain. To maintain the redox equilibrium, the
oxidative status in stem cells is regulated by the controlled
balance of ROS production and scavenging, through the
generation of endogenous antioxidants. Therefore, under-
standing the cellular redox state is important to modulate
stem cell survival, expansion, and differentiation.
2.1. ROS Generation in Stem Cells. ROS is mainly produced
in mitochondria of the cells. The primary source of mito-
chondrial ROS is the leakage of a small fraction of respiratory
chain electrons (1-2%), which react with molecular O
2
to
form superoxide ions O
2
−∙, a precursor of various types of
ROS (Figure 1(a)) [13]. The dismutation of O
2
−∙ generates
H
2
O
2
and this reaction is catalyzed by superoxide dismu-
tases (SOD) such as MnSOD [13]. Several mitochondrial
complexes of the electron transport chain contribute to the
ROS generation in MSCs and PSCs. Complex I is composed
of nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases (NOXs) [13], the transmembrane proteins that
catalyze the oxidation of NAPDH (Figure 1(b)). NOX-1 and
NOX-4 are the most expressed NOX isoforms in MSCs and
PSCs, and these enzymes significantly contribute to total ROS
generation in the cells [14, 15]. Importantly, activation of
Ras-related C3 botulinum toxin substrate 1 (Rac-1), a Rho
GTPase, is required for ROS generation mediated by NOXs
[16]. Complex II comprises succinate dehydrogenases, which
are expressed at significant levels in undifferentiated MSCs
and PSCs [17, 18]. Succinate dehydrogenase catalyzes the
oxidation of succinate to fumarate. This reaction is mediated
by the conversion of flavin adenine dinucleotide (FAD) to
FADH2, where the intermediary electron transfer promotes
ROS generation [19]. Complex III contains the ubiquinol-
cytochrome c reductases, which catalyze the reduction of
cytochrome c by the oxidation of coenzyme Q (Figure 1(c)).
The electron leakage from the reduction of cytochrome c
leads to the ROS generation [13]. Therefore, treatment of
PSCs andMSCs with antimycin A (a cytochrome c reductase
inhibitor) increases ROS generation [20, 21]. Complex IV is
composed of cytochrome c oxidase, which mediates the oxi-
dation of cytochrome c [13]. While the presence of complex
IV has been characterized in PSCs andMSCs [22, 23], limited
information is available on its contribution toROS generation
in stem cells.
The specific contribution of each mitochondrial complex
to the level of ROS generation in stem cells has not been
well understood and thus remains to be further explored. In
addition, various metabolic intermediates of oxidative phos-
phorylation (e.g., 2-oxoglutarate dehydrogenase, pyruvate
dehydrogenase, glycerol 3-phosphate dehydrogenase etc.)
contribute differently to the level of ROS production in the
specified sites of mitochondria [24]. While the ROS are
mainly generated from mitochondria, other cellular com-
partments such as endoplasmic reticulum or lysosomes also
contribute to the generation of prooxidative molecules [25].
These additional sources of ROS may also play important
roles in the regulation of cellular redox status.
2.2. ROS Scavenging in Stem Cells. To counteract excessive
accumulation of ROS, various types of scavengers are gen-
erated to regulate the redox homeostasis in stem cells, which
include SODs, glutathione peroxidase (Gpx), preoxiredoxins
(Prx), and lysosomal catalases (CAT) [26]. SOD enables the
conversion of O
2
∙− to O
2
and H
2
O
2
by sequential oxidation-
reduction of metalloproteins (i.e., Zn or Mn bound proteins)
of the enzyme catalytic sites as well as the concomitant
oxidation-reduction of superoxide ions [27]. Gpx enables
the H
2
O
2
reduction, in which seleno-cysteine of the enzyme
serves as the substrate [28]. H
2
O
2
is converted to H
2
O by
the oxidation of N-terminal cysteine of Prxs, resulting in
the formation of Prx homodimer [29]. Also, H
2
O
2
reacts
with various ferric states of the heme of the catalytic site of
CAT, which enables its dismutation in a two-electron redox
reaction (Figure 1(c)) [30].
The expression of cystine transporters (i.e., xCT
antiporter) plays a key role in maintaining the level of
antioxidant synthesis [31]. Indeed, cysteine is the major
amino acid source for Gpx synthesis. However, upon
oxidation in air, cysteine is converted to cystine. Facilitating
the transport of cystine to cytoplasm through xCT enables
the reconversion of cystine to cysteine and consequently the
sustained synthesis of Gpx [31]. Moreover, under oxidative
stress, the induction of nuclear factor erythroid 2-related
factor 2 (Nrf-2), a regulator of the cystine transporter,
leads to the increased xCT expression which results in the
enhanced Gpx production [31].
Human MSCs have oxidative defense mechanism and
resistance to oxidative stress. For example, MSCs express
significant levels of active forms of CAT, GPx, and SOD,
which confers the resistance against acute ROS-mediated
apoptosis [32, 33]. Indeed, the knockdown of Gpx reduces
the viability when MSCs are exposed to high concentra-
tion of H
2
O
2
[32]. Similarly, the activities of SOD, Gpx,
and CAT are significantly diminished in culture medium
containing the reduced concentration of selenite [33].
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Figure 1: ROS generation and scavenging in stem cells. (a) ROS generation. ROS generation is initiated with the electron transfer tomolecular
O
2
, leading to the formation superoxide radicals (O
2
−∙), a precursor of the various ROS. Hydroxyl radicals (OH∙) are generated from O
2
−∙
through a Fenton reaction. Alternatively, SOD catalyzes the formation of hydrogen peroxide (H
2
O
2
). (b) ROS are mainly generated at various
complex of the respiratory chain, located in the inter-membrane space of the mitochondria. (c) ROS scavenging. The degradation of ROS is
catalyzed by scavenging proteins, that is, glutathione peroxidases, catalase, and peroxiredoxin (Prx). Prx are dimers, which contain cysteine
(–SH groups) (1). In the presence of H
2
O
2
, the cysteine –SH groups are oxidized to –SOH (2), which then condensed to form disulfide groups
(S–S) (3). The S–S groups of Prx are reduced by thioredoxin (Trx) to return to the initial –SH form (1). PRX-SOH can be overoxidized by
H
2
O
2
to form Prx-SO
2
H groups (4).
The enrichment of selenite promotes Gpx and thioredoxin
(Trx) activities, leading to the better resistance against oxida-
tive stress induced by H
2
O
2
[33]. In addition, MSCs express
xCT which enables efficient cystine transport and results in
the significant expression of Gpx [34, 35]. Moreover, upon
acute oxidative stress, the activation of Nrf-2 leads to the
increased Gpx expression [36].
Undifferentiated PSCs exhibit the increased oxidative
defense compared to the differentiated cells [37]. Indeed,
ESCs express a significant amount of Gpx-1, which is required
to sustain their self-renewal [38]. Also, both human and
mouse ESCs express large amounts of Gpx-1, SOD, Prx, and
Trx, which are down-regulated during differentiation and
are associated with the increased levels of intracellular ROS
[37, 39]. PSCs also express a large amount of Nrf-2, which
is down-regulated during spontaneous differentiation [40].
Under oxidative stress, increased Nrf-2 nuclear translocation
has been observed in ESCs, which is linked to the enhanced
expression of thioredoxin reductase 1, Gpx-1, and Gpx-4
[41]. However, it is suggested that undifferentiated PSCs do
not express xCT [31]. As a consequence, PSCs are usually
cultivated on feeder layers, which are necessary to provide
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a sufficient amount of cysteine for Gpx expression. Alter-
natively, addition of 𝛽-mercaptoethanol to the PSC culture
medium enables the stabilization of cysteine [31].
3. Physiological Roles of ROS in
Stem Cell Homeostasis
A tight balance between ROS generation and antioxidant
protein synthesis regulates the redox homeostasis in stem
cells [42]. Basal levels of ROS are required for the activation
of several key cellular pathways for stem cell proliferation and
survival. In the meanwhile excessive accumulation of ROS
leads to cellular damage.
3.1. Low Levels of ROS Are Secondary Signaling Messengers for
Cell Proliferation and Survival. Low concentrations of exoge-
nous H
2
O
2
, inhibitors of the mitochondrial electron transfer
(e.g., antimycin A, rotenone), and hypoxia induce moderate
levels of ROS in MSCs. Low levels of ROS are reported to
enhance MSC proliferation and migration through the acti-
vation of extracellular-signal-regulated kinases (ERK) 1/2 and
Jun-1/2 pathways [43–45].Thepositive effects of ROSonMSC
expansion are mediated by NOXs. Indeed, the knockdown of
NOX-1 and NOX-4 prevents the proliferation of MSCs under
hypoxia or upon cultivation in IL-7 containing medium [46].
In addition, growth factors such as platelet-derived growth
factor-BB lead to the mild ROS generation which increases
the proliferation and migration of adipose-derived MSCs
[47]. As recently demonstrated, various mild ROS inducers
(i.e., hypoxia, mitochondrial inhibitors, growth factors etc.)
converge to activate miR-210, a miRNA that triggers ERK1/2
andAKT activation inMSCs (Figure 2(a)) [47]. Alternatively,
moderate levels of ROS regulate the secretory function of
MSCs. For instance, the induction of ROS with advanced
glycation end products (AGE) is reported to promote the
secretion of chemokines (e.g., CCL-2, CCL-4) by MSCs,
through the activation of p38-mitogen-activated protein
kinases (MAPK) pathway [48]. Also, hypoxia-induced ROS
mediates pro-angiogenic function of MSCs (i.e., secretion of
vascular endothelial growth factor (VEGF)) [10]. As reported
for various cell types, NOXs may play a role in the trophic
function through ROS generation (Figure 2(a)) [49].
Low levels of ROS generated from hypoxia also mediate
the proliferation of PSCs, through the enhanced activation
of the MAPK, nuclear factor-𝜅B (NF-𝜅B), and Wnt signaling
(Figure 2(a)) [11, 50]. Moreover, the genetic stability of ESCs
requires basal levels of ROS expression [51]. Indeed, the inhi-
bition of ROS generation via acute dose of antioxidants (e.g.,
CAT) is reported to inhibit the activity of phosphorylated
ataxia telangiectasia mutated (pATM), a serine/threonine
protein kinase that is activated by DNA double-strand
breaks. Inhibition of pATM activity is normally required
for maintaining DNA integrity (Figure 2(a)) [51]. Also, the
antibacterial function of ESCs is found to be controlled by
the sustained expression of NOX-2 [52]. Hence, moderate
levels of ROS support important physiological functions in
stem cells. In contrast, the abrogation of ROS generation
leads to “reductive stress” that significantly alters stem cell
homeostasis [53].
3.2. Pathological Levels of ROS Accumulation Lead to Oxida-
tive Stress and Cell Damage. Excessive generation of endoge-
nous ROS and the imbalance between ROS and antioxidant
proteins, as well as the culture of stem cells with various
extracellular sources of ROS can lead to oxidative stress in
stem cells (Figure 2(b)). For examples, aging significantly
contributes to endogenously induced redox imbalance in
MSCs [54]. The production of AGE, by-products of glycol-
ysis, also leads to oxidative stress in MSCs [55]. In addition,
some culture conditions such as the cryopreservation and the
irradiation result in acute oxidative damages in PSCs and
MSCs through endogenous ROS production [56, 57]. The
presence of circulating cell-free DNA in culture medium has
also been reported to induce oxidative stress in MSCs [36].
Moreover, exogenous H
2
O
2
can diffuse through cytoplasmic
membrane, leading to the oxidative stress in PSCs andMSCs.
Of importance, the paracrine diffusion of endogenous ROS
in MSCs has been demonstrated, indicating the propagation
of oxidative imbalance at the cellular level [58].
Oxidative stress due to high levels of ROS impairs stem
cell homeostasis. Indeed, high levels of ROS disturb MSC
adhesion through the down-regulation of the activated focal
adhesion kinase (FAK), Src, and the integrin expression
(Figure 2(b)) [59]. In addition, oxidative stress leads to DNA
damage in MSCs through the induction of the colocalization
of ATM, H2A.X, and 53BP1 genes, the specific DNA damage
response [60]. Similarly, oxidative stress reduces the telomere
length of MSCs by decreasing the expression of telomeric
repeat binding factor (TRF) 1 and TRF2 (two proteins
involved in telomere elongation and stabilization), leading
to the cell senescence (Figure 2(b)) [60, 61]. In contrast, it
has been demonstrated that PSCs are less prone to DNA
damage and the senescence induced by oxidative stress, due
to the capability for the repair of DNA double-strand breaks
[57, 62].
Oxidative stress also causes cell cycle arrest in stem
cells. High ROS has been found to mediate the activation
of p38-MAPK and p16, which inhibits the phosphorylated
retinoblastoma (pRB) protein and causes the growth arrest
of MSCs [63]. In addition, ROS has been reported to induce
growth inhibition through the activation of p53 inMSCs [64].
Similarly, cell cycle arrest can be induced in mouse ESCs
under oxidative stress [57, 62], as a consequence of c-Jun N-
terminal kinase (JNK) and p53 activation (Figure 2(b)) [65].
Finally, excessive levels of ROS promote the apoptosis in
MSCs and PSCs [62, 66]. Indeed, under oxidative stress ROS
disrupts mitochondrial cardiolipin-cytochrome c complexes,
liberating cytochrome c in a free form. In addition, ROS
induces the BAX-BAK dimerization, enabling the formation
of channels on the mitochondrial membrane and thus facil-
itating the translocation of cytochrome c to the cytoplasm.
The cytoplasmic cytochrome c activates the expression of
caspases, leading to apoptosis (Figure 2(b)) [67].
Hence, ROS play dual role in stem cell homeostasis,
depending on the level of production. The exact threshold
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Figure 2: Regulation of stem cell proliferation and survival by ROS. (a) Effect of physiological levels of ROS. Physiological levels of ROS
activate various MAPKs (i.e., ERK, p38, and AKT), promoting stem cell proliferation. Mir-210 is upregulated by ROS and is also involved
in the MAPK activation, leading to the enhanced stem cell proliferation. Mild levels of ROS promote the activation of pATM, increasing
the DNA stability of stem cells. Mild ROS can sustain antibacterial properties of PSCs and the proangiogenic functions of MSCs. (b) Effect
of excessive levels of ROS. Excessive levels of ROS induce oxidative stress in stem cells. High levels of ROS result in a decreased stem cell
adhesion (i.e., through a decreased activation of FAK-Src signaling) and proliferation (through the reduced activation of pRB). High ROS
also reduce DNA stability and induce apoptosis (in favoring BAX-BAK dimerization and the formation of channel facilitating cytochrome c
(cyt c) cytoplasmic translocation). In (a), Cyt c red means Cyt c reductase.
level of ROS to decipher between its role as a secondary
physiological messenger or as a source of oxidative stress still
needs to be further delineated.
4. ROS Regulates the Balance between
Self-Renewal and Differentiation of
Stem Cells
ROS and the oxidative defense signaling interfere with MSC
and PSC differentiation pathways. The regulation of oxidant
defense between undifferentiated stem cells and their differ-
entiated progeny indicates the important role of ROS in the
regulation of stem cell fate.
4.1. Mesenchymal Stem Cells. MSCs have low numbers
of mitochondria at the undifferentiated state, while the
increased mitochondrial biogenesis and oxidative phospho-
rylation (OXPHOS) supercomplexes are observed during
differentiation [18, 23].Therefore, the redox status is changed
upon MSC differentiation and the spontaneous increase in
ROS generation occurs during osteogenic and adipogenic
differentiation (Figure 3(a)) [68]. However, MSCs display the
unique redox profile depending on the differentiation path.
For instance, MSCs committed to adipocyte lineage show
the increased cysteine redox potential compared to the cells
committed to osteoblast lineage [68].
During adipogenic differentiation of MSCs, ROS genera-
tion is increased through the mediation by NOX-4 [69, 70].
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Figure 3: Regulation of stem cell self-renewal, differentiation, and reprogramming by ROS. (a) MSCs. MSCs have low numbers of
mitochondria that generate low levels of ROS at undifferentiated state. Low ROS generation sustains the capability of forming colony-
forming unit-fibroblasts (CFU-F). Upon differentiation, the number of mitochondria and the ROS levels are increased. ROS promotes the
adipogenesis, osteogenesis, and chondrogenesis from MSCs. (b) PSCs. Undifferentiated PSCs have low mitochondrial biogenesis, which
increases upon differentiation.Mild levels of ROS promote PSC self-renewal and the expression of Oct-4, NANOG, and SOX-2. Alternatively,
the spontaneous and lineage-specific differentiations are associated with the increased ROS generation. For examples, ROS triggers PI3K and
p38, which support cardiomyogenic differentiation. ROS also enhances neuronal differentiation through JNK activation. (c) iPSCs. During
reprogramming, iPSCs show the decreased mitochondria biogenesis and a reduction of ROS production compared to the somatic cells.
Increasing ROS scavenging during reprogramming enhances the efficiency of iPSC generation, which depends on the methods of OKSM
(Oct-4, Klf-4, SOX-2, and c-MYC) transfection.
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Inhibition of mitochondrial complex III and complex I
significantly reduces the expression of CCAAT-enhancer-
binding protein (C/EBP)-𝛽 and peroxisome proliferator-
activated receptor (PPAR)-𝛾, the markers for adipocyte dif-
ferentiation [69]. However, NOX-4 silencing (by siRNA) did
not attenuate C/EBP-𝛽 or PPAR-𝛾 expression but reduced
lipid accumulation, indicating the contribution of NOX-4
at late stage of adipogenic differentiation [69, 70]. Similarly,
the activation of mammalian target of rapamycin (mTOR)
signaling promotes ROS generationmediated by complex III,
which induces the expression of PPAR-𝛾 (Figure 3(a)) [15].
To balance the increased ROS expression, adipogenic differ-
entiation is associated with the up-regulation of Forkhead
box Os (FoXOs) which regulate the expression of antioxidant
enzymes (e.g. catalases, SODs, and Gpxs) [71]. However, Sirt-
1 (an activator of FoXO-1) reduces adipogenic differentiation
potentially by deacetylating PPAR-𝛾 or impairing the forma-
tion of FoXO-1/PPAR-𝛾 complexes [72, 73]. Similarly, Sirt-2
reduces adipogenic differentiation by deacetylating FoXO-1,
which promotes nuclear localization of FoXO-1 [74].
During osteogenic differentiation of MSCs, canonical
Wnt/𝛽-catenin induces ROS generation and plays a critical
role in the regulation of MSC differentiation by activating
osteogenesis and inhibiting adipogenesis [75]. To balance the
ROS effects, the activation of FoXO-1 promotes osteogenic
differentiation by regulating the expression of RUNX-2, a
master regulatory factor of osteogenesis [76].Moreover, Sirt-1
enables the deacetylation of 𝛽-catenin and promotes nuclear
accumulation of 𝛽-catenin, which acts as a transcription
factor of osteogenic genes [77]. The imbalance between the
level of ROS and the expression of scavenging proteins
can lead to the reduced osteogenic differentiation of MSCs
(Figure 3(a)) [78].
ROS generation is also increased during chondrogenic
differentiation [79]. ROS produced through NOX-2 and
NOX-4 promotes cell survival during chondrogenesis [79].
Moreover, endogenousROS triggersAKTandERK signaling,
leading to the enhanced expression of SOX-9, collagen type
II and the accumulation of proteoglycans (Figure 3(a)) [79].
Sirt-1 is required for chondrogenic differentiation of MSCs
through the activation of SOX-9 as well as the deacetylation
of NF-𝜅B, leading to the decreased expression of matrix
metalloproteinase (MMP)-9, COX-2, and caspase-3 [80].
Finally, the FoXOs enhance the survival of MSCs and prevent
the differentiation towards hypertrophic chondrocytes (i.e.,
indicated by the expression of collagen type X) [81].
4.2. Pluripotent Stem Cells. PSCs display low levels of ROS
expression at the undifferentiated state as a consequence of
a low level of mitochondrial biogenesis and a high level
of ROS scavenging protein expression (e.g. Gpx-1) [38, 82].
The basal levels of ROS are required to sustain the self-
renewal of PSCs [17, 83]. Indeed, it is recently demon-
strated that ROS modulates Oct-4 posttranslational modi-
fications (such as sumoylation and ubiquitination), leading
to the enhanced nuclear localization of Oct-4 [84]. Sirt-1,
a key cell survival factor activated upon ROS exposure, is
down-regulated during ROS-induced differentiation through
the activity of miR-29b [85]. Sirt-1 also regulates the activa-
tion of FoXOs which are required to maintain pluripotency
by directly regulating the expression levels of Oct-4, Nanog,
and SOX-2 in human ESCs (Figure 3(b)) [86, 87].
The redox status of PSCs changes significantly dur-
ing spontaneous differentiation. Indeed, ROS expression is
increased upon PSC lineage commitment as a consequence of
the regulation of scavenging protein expression. For instance,
the expressions of Prx-1, SOD2, Gpxs and CAT are found
lower in embryoid bodies compared to undifferentiated
ESCs [37, 88]. ROS generation by retinoic acid enables the
activation of Wnt signaling through the increased expression
of NOXs during extra-embryonic endodermal differentiation
(i.e., indicated by the expressions of GATA-6 and FOXa2)
of PSCs [89, 90]. In addition, ROS generation through
the inhibition of glutathione mediates the differentiation of
human ESCs towards mesodermal (i.e., indicated by the
expression of brachyury, myogenin, and myogenic factor 6)
and endodermal lineages (i.e., indicated by the expression
of HNF3𝛽, AFP, and Sox17) [91]. ROS is found to regulate
meso-endodermal specification through the modulation of
the MAPKs, such as the inactivation of p38 and AKT as well
as concomitant transient increase of JNK and ERK signaling
(Figure 3(b)) [91].
ROS also mediates the lineage-specific differentiation
of PSCs. For instance, the icariin-induced ROS production
throughNOX-4 promotes ESCdifferentiation into cardiomy-
ocytes [92]. ROS can trigger p38 activation and phosphatidyl-
inositol-4,5-bisphosphate 3-kinase (PI3K) expression, which
mediate MEF2C nuclear translocation, a key transcription
factor in ESC cardiac differentiation [93]. ROS produced
during cardiac differentiation is also found to activate NF-𝜅B
signaling and trigger phosphatidylinositol 3-kinase enhancer
(PIKE) and PI3K activation [94]. Similarly, ESC differen-
tiation into smooth muscle cells shows the increased ROS
production, which mediates the nuclear translocation of
serum response factor (SRF), a transcription factor specific
for smooth muscle cells [95]. Neural differentiation of ESCs
also demonstrates the increased ROS generation through the
regulation of antioxidant protein expression [88]. Indeed,
it has been recently demonstrated that the Prxs knock-
down in mouse ESCs prevents ROS-mediated activation of
JNK signaling, which is required for neuronal differentiation
(Figure 3(b)) [88].
4.3. Influence of ROS during iPSC Reprogramming. Recently,
the reprogramming of somatic cells through forced expres-
sion of a set of genes (Oct-4, KL-4, SOX-2, and c-MYC, i.e.,
OKSM) enables the generation of iPSCs that display ESC-like
properties [4]. Both iPSCs and ESCs demonstrate low redox
status and the capability for DNA repair following oxidative
damage [96]. Importantly, the somatic mitochondria can
revert to an ESC-like state in terms of morphology, cellular
distribution, and rate of biogenesis after reprogramming
(Figure 3(c)) [97].
However, somatic cell reprogramming to derive iPSCs
through viral transfection is associated with a high level
of ROS which leads to oxidative damage [98, 99]. The
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Figure 4: Modulation of ROS level regulates the stem cell fate decision. ROS play dual role in stem cell homeostasis, depending on its level of
production. At mild levels, ROS serves as a secondary physiological messenger. At high levels, ROS is a source of oxidative stress that leads to
cell apoptosis. Tight regulation of biochemical and biomechanical environment can control stem cell oxidative status and thus the stem cell
fate decision.
oxidative stress generated during reprogramming impairs cell
survival and promotes genetic aberrations [98, 99]. Addition
of antioxidants (such as N-acetylcysteine or vitamin C)
improves the reprogramming efficiency and reduces genetic
abnormalities [98, 99]. Among OKSM genes, c-MYC is
reported to be involved in a high level of ROS generation
during iPSC derivation [98]. In addition, various methods of
reprogramming lead to different levels of ROS generation. For
instance, the episomal transfection of OKSM generates lower
amounts of ROS than the viral-based reprogramming [100].
Together, ROS play an important role in the regulation
of stem cell self-renewal, differentiation and reprogramming.
However, the threshold levels for ROS and the regulation of
scavenging protein expression tomodulate stem cell fates still
need to be defined.
5. Modulation of ROS Generation through
Stem Cell Microenvironment
Stem cell microenvironment including cellular organization
and physiological parameters is a potent regulator of ROS
generation. Modulating stem cell microenvironment could
lead to a better control of redox status for stem cell prolifer-
ation and differentiation. The contribution of the respiratory
chain in ROS generation suggests the intricate link between
stem cell metabolism and ROS generation [101]. In addition,
the pathway involving Rac-1 is activated in MSCs and PSCs
upon biomechanical stimulation, indicating the relation of
mechano-transduction with ROS generation.Thus, tight reg-
ulation of biochemical and biomechanical environment can
control stem cell oxidative status towards efficient expansion
and differentiation (Figure 4).
5.1. Biochemical and Metabolic Regulation of ROS Generation.
The metabolism of undifferentiated MSCs and PSCs mainly
relies on glycolysis, while a metabolic shift towards OXPHOS
is generally observed upon differentiation [12]. The reverse
process is also demonstrated during reprogramming where
the metabolism of somatic cells shifts from OXPHOS to gly-
colysis when gaining pluripotency [12]. OXPHOS mediates
the production of ROS as a consequence of electron leakage
from the respiratory chain. Due to the dominant glycolytic
metabolism, undifferentiatedMSCs and PSCs generate lower
levels of ROS than their differentiated counterparts [101].
Due to the involvement of glucose inmetabolic pathways,
glucose concentration in the culture medium affects ROS
generation in stem cells, through the regulation in the expres-
sion of mitochondrial complexes [102]. As a consequence,
ROS production is increased when MSCs and PSCs are
cultivated in the medium containing a high level of glucose,
while the low-glucose medium attenuates the production
of ROS and induces antioxidant secretion in MSCs (e.g.,
MnSOD or catalase) [102, 103].
Oxygen tension within the stem cell microenvironment
also regulates ROS generation. Low oxygen tension (i.e.,
hypoxia) favors glycolysis, leading to the reduced ROS pro-
duction through the metabolism of MSCs and PSCs [104,
105].However, a rapid transient increase of physiological ROS
has been observed under hypoxia. The hypoxia-generated
ROS is mediated through the complex III and NOXs which
enable the activation of MAPK and the stabilization of
hypoxia inducible factors (HIF) to regulate the survival and
proliferation of MSCs and PSCs [106, 107]. In addition,
hypoxia increases the reprogramming efficiency of somatic
cells, potentially due to the reduced oxidative stress and the
promotion of glycolysis through the stabilization of HIF-1𝛼
[108].
Interactions between the effects of glucose concentration
and oxygen tension are observed for ROS generation in
stem cells. Indeed, while low glucose condition reduces the
ROS production, high glucose condition in combinationwith
hypoxia induces oxidative stress, impairing the stem cell
survival and function such as the secretion of proangiogenic
factors [8]. It has been found that high glucose under hypoxia
promotes the degradation of HIF-1𝛼 through the increased
proteasome activity [8]. All these observations indicate that
controlling stem cell metabolic environment can modulate
ROS generation.
5.2. Biomechanical Signals Regulate ROS Generation. Rac-1 is
a member of Rho-GTPases and is involved in cell-cell and
cell-matrix adhesion, the cytoplasmic membrane ruffling,
and lamelipodia elongation [109, 110]. Rac-1 is found to play
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a key role in the generation of ROS. Indeed, the enzymatic
activity of NOXs (i.e., the conversion of NADPH toNADP) is
mediated by the interactions of the enzyme’s several subunits
(p22phox, p47phox, 40phox, and p67phox) and Rac-1 [111].
Consequently, Rac-1 plays a key role in the regulation of PSC
and MSC proliferation, migration and differentiation [112–
114].
The biomechanical environment of PSCs andMSCs (such
as surface pattern or stiffness) can modulate Rac-1 activation
[113, 115, 116], which in turn mediates ROS generation. For
example, the application of cyclic strains to mouse ESCs
promotes ROS generation, which induces cardiomyogenic
differentiation [14, 117]. A gradual increase in ROS generation
and a concomitant decrease in SOD expression have been
observed when increasing the magnitude of cyclic strain
that is applied to MSCs (6 to 24% magnitude) [118]. The
biomechanical regulation of ROS generation in stem cells is
an emerging area and needs further exploration.
5.3. Extracellular Matrix and Cell Aggregation as the Modu-
lators of Redox Status. Extracellular matrix (ECM) may bear
antioxidant properties that protect stem cells from oxidative
damages [119, 120]. For instance, it has been demonstrated
that young endogenous ECM derived from MSCs reduces
ROS production compared to old ECMor plastic dishes [119].
The endogenous glycosaminoglycans such as chondroitin
sulfate or small leucine-rich proteoglycans have antioxidant
properties, which may mediate stem cell oxidative defense
[119, 121]. Alternatively, decellularized ECM from MSCs has
been shown to promote the resistance against oxidative stress
through the secretion of endogenous antioxidants such as
SOD2 [122]. It has been demonstrated that ECM proteins are
the targets of ROS through the activation of MMPs, which
can affect MSC motility [123].
The formation of MSC aggregates promotes the secretion
of ROS scavenging proteins such as SOD2, leading to the
increased resistance of MSCs against acute H
2
O
2
exposure
[124, 125]. The increased secretion of antioxidant proteins
might be due to mild hypoxia found in the core of MSC
aggregates [124]. Similarly, PSC aggregates can display the
increased anti-oxidative defense upon acute ROS generation
(e.g., after cryopreservation) [56]. However, the molecular
mechanism conferring oxidative defense in stem cell aggre-
gates is still unclear.
6. Conclusions
While high levels of ROS have detrimental effects on stem
cells through the induction of oxidative stress, physiological
levels of ROS play an important role in the regulation of
stem cell fate decision. Mild levels of ROS act as secondary
messengers by interfering with various signaling pathways
that regulate stem cell proliferation, survival, and differenti-
ation. However, the contribution of the specific site of ROS
production and the specific type of ROS in the regulation
of stem cell fate requires further delineation. In addition,
the exact threshold levels of ROS deciphering between the
role as damaging molecules or as enhancers of stem cell
signaling pathway are not clearly defined.Therefore, methods
for the in situ detection of ROS level and the specific species
are required to accurately quantify and characterize the
threshold level of ROS to modulate stem cell homeostasis.
For instance, the application of Raman spectrometry or
alternative probes may be preferred to measure intracellular
ROS [126]. Combined with accurate ROS measurement,
regulation of biochemical and biomechanical environment of
stem cells to modulate redox status can lead to the controlled
proliferation and differentiation of stem cells towards various
biomedical applications.
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